Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?

Oracle co-founder and the company’s executive chairman and chief technology officer Larry Ellison (above left) is trying to persuade governments to descend deep into AI-powered surveillance dystopia ...

We recently compiled a list of the 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look ...

The $500 billion Stargate project is projected to create hundreds of thousands of jobs. Here's what's known so far.

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

Oracle Chairman Larry Ellison asserted that AI could be used to assist in the development of mRNA-based cancer vaccines. His statement resulted in a 7% rally by MRNA stock on Jan. 22. The shares ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman Cut Its Rating on MRNA Earlier this month, Moderna reduced its 2025 ...

In 2025, the AI landscape is undergoing a transformative shift, expanding into two critical new layers: the application layer and the data infrastructure layer.

Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

Oracle founder Larry Ellison, who was last seen with US President Donald Trump, signing an all-important USD 500 billion AI infrastructure deal saw one of the biggest decline in personal wealth.

Bryan Johnson highlights Larry Ellison's views on AI revolutionizing healthcare, particularly in cancer detection, treatment, and vaccine development. Larry Ellison mentions the construction of ...